PIMJS
WST icon

PKO Investment Management Joint-Stock’s West Pharmaceutical WST Stock Holding History

PKO Investment Management Joint-Stock’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$287K Hold
800
– – 0.02% 216
2026
Q1 		$201K Hold
800
– – 0.02% 209
2025
Q4 		$220K Sell
800
-400
-33% -$109K 0.02% 212
2025
Q3 		$315K Buy
+1,200
New +$292K 0.03% 187

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Generation Investment Management
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

PKO Investment Management Joint-Stock's WST Position: Q2 2026 in Review

PKO Investment Management Joint-Stock held its West Pharmaceutical (WST) position steady in Q2 2026 at 800 shares worth $287K. The position accounts for 0.02% of the portfolio, ranked #216.

PKO Investment Management Joint-Stock first reported a position in WST in Q3 2025 and has held it in 4 quarters since. The position peaked at $315K in Q3 2025. 835 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • PKO Investment Management Joint-Stock held 800 shares of West Pharmaceutical worth $287K as of Q2 2026.
  • PKO Investment Management Joint-Stock left its West Pharmaceutical share count unchanged in Q2 2026.
  • West Pharmaceutical made up 0.02% of PKO Investment Management Joint-Stock's portfolio in Q2 2026, its #216 holding.
  • PKO Investment Management Joint-Stock first reported a position in West Pharmaceutical in Q3 2025 and has held it in 4 quarters since.
  • PKO Investment Management Joint-Stock's West Pharmaceutical position peaked at $315K in Q3 2025.
  • 835 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on PKO Investment Management Joint-Stock's 13F filing for Q2 2026, filed 20 Jul 2026.